A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Abbott sells market-leading products across its businesses, from the Ensure brand in its nutrition business to the FreeStyle Libre continuous glucose monitoring (CGM) system in its medical devices ...

Built on the FreeStyle Libre continuous glucose monitoring technology—now used by more than 6 million people with diabetes globally—Lingo tracks users' glucose levels continuously. The system is ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Built on the FreeStyle Libre continuous glucose monitoring technology—now used by more than 6 million people with diabetes globally—Lingo tracks users' glucose levels continuously. The system ...

We like that management has turned its attention to new sources of growth. In our view, Abbott's FreeStyle Libre blood glucose monitor franchise is one of the most compelling innovations the firm ...

CEO Robert Ford said in an earnings call in October that the potential for Abbott's FreeStyle Libre CGM is a “mass market opportunity.” There are about 10 million CGM users worldwide ...

During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...

The Diabetes Care unit within Medical Devices saw 20.1% growth, driven by strong demand for the FreeStyle Libre continuous glucose monitoring system. The company's board declared a quarterly dividend ...

Freestyle Chess, also known as Fischer Random, radically reimagines the game by randomising the placement of back-rank pieces like the king, queen and bishops, leaving pawns untouched. This ...